John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$976M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$219M |
| 3 |
Humana
HUM
|
+$215M |
| 4 |
Pinterest
PINS
|
+$214M |
| 5 |
Snowflake
SNOW
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$301M |
| 2 |
Tesla
TSLA
|
+$254M |
| 3 |
Nike
NKE
|
+$248M |
| 4 |
Procter & Gamble
PG
|
+$233M |
| 5 |
Pfizer
PFE
|
+$232M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.09% |
| 2 | Financials | 10.23% |
| 3 | Consumer Discretionary | 10.17% |
| 4 | Healthcare | 10.17% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Third Coast Bancshares
TCBX
$756M
| $236K | ﹤0.01% |
11,879
-7,487
| -39% | -$130K |
|
2727
TCW Transform 500 ETF
VOTE
$1.13B
| $234K | ﹤0.01% |
+4,200
| New | +$218K |
|
2728
MoonLake Immunotherapeutics
MLTX
$1.32B
| $233K | ﹤0.01% |
3,853
| – | – |
|
|
FNA
2729
DELISTED
Paragon 28, Inc.
FNA
| $233K | ﹤0.01% |
+18,719
| New | +$198K |
|
2730
BioNTech
BNTX
$28.6B
| $232K | ﹤0.01% |
2,200
-6,100
| -73% | -$615K |
|
2731
First Merchants
FRME
$2.6B
| $232K | ﹤0.01% |
6,249
-69,261
| -92% | -$2.15M |
|
2732
Pharvaris
PHVS
$2.6B
| $230K | ﹤0.01% |
+8,198
| New | +$166K |
|
2733
Eton Pharmaceutcials
ETON
$1.79B
| $230K | ﹤0.01% |
52,500
-27,052
| -34% | -$108K |
|
2734
Akebia Therapeutics
AKBA
$266M
| $230K | ﹤0.01% |
185,399
+157,938
| +575% | +$161K |
|
2735
Xeris Biopharma Holdings
XERS
$1.58B
| $229K | ﹤0.01% |
97,349
-12,577
| -11% | -$23.2K |
|
|
INZY
2736
DELISTED
Inozyme Pharma
INZY
| $229K | ﹤0.01% |
53,700
-14,400
| -21% | -$51.2K |
|
2737
Solid Biosciences
SLDB
$1.06B
| $228K | ﹤0.01% |
+37,198
| New | +$119K |
|
|
TVRD
2738
Tvardi Therapeutics
TVRD
$24.3M
| $228K | ﹤0.01% |
8,535
+6,597
| +340% | +$273K |
|
2739
QCR Holdings
QCRH
$1.63B
| $228K | ﹤0.01% |
+3,905
| New | +$202K |
|
2740
Red Robin
RRGB
$183M
| $227K | ﹤0.01% |
18,208
-43,669
| -71% | -$407K |
|
|
KREF
2741
KKR Real Estate Finance Trust
KREF
$491M
| $227K | ﹤0.01% |
+17,133
| New | +$205K |
|
2742
WesBanco
WSBC
$3.87B
| $226K | ﹤0.01% |
7,200
-71,218
| -91% | -$1.91M |
|
|
EH
2743
EHang Holdings
EH
$363M
| $226K | ﹤0.01% |
13,435
+1,935
| +17% | +$31.6K |
|
|
MFA
2744
MFA Financial
MFA
$894M
| $226K | ﹤0.01% |
20,017
-3,876
| -16% | -$39.2K |
|
2745
UMB Financial
UMBF
$10.9B
| $226K | ﹤0.01% |
2,700
-5,429
| -67% | -$382K |
|
2746
InflaRx
IFRX
$342M
| $226K | ﹤0.01% |
138,375
+125,950
| +1,014% | +$216K |
|
2747
Invivyd
IVVD
$276M
| $224K | ﹤0.01% |
+56,854
| New | +$108K |
|
|
RERE
2748
ATRenew
RERE
$879M
| $224K | ﹤0.01% |
116,516
+89,900
| +338% | +$158K |
|
2749
Hancock Whitney
HWC
$5.97B
| $224K | ﹤0.01% |
4,600
-71,074
| -94% | -$2.84M |
|
2750
Star Group
SGU
$414M
| $223K | ﹤0.01% |
+19,360
| New | +$235K |
|
Similar funds
John Overdeck's Q4 2023 Portfolio in Review
As of Q4 2023, John Overdeck held 3,484 positions worth $43.5B, up 17% from $37.2B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
John Overdeck's Q4 2023 filing shows 550 new, 1,237 increased, 1,116 reduced and 366 closed positions. Its largest new stake was Becton Dickinson: 732,254 shares worth $179M. The largest sale was Palantir, an estimated $301M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
- John Overdeck's largest Q4 2023 buy was Becton Dickinson: 732,254 shares worth $179M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $976M increase.
- John Overdeck's biggest Q4 2023 reduction was Palantir, cutting an estimated $301M.
- John Overdeck fully exited Tesla in Q4 2023, selling an estimated $254M.
- John Overdeck's ten largest holdings make up 9.3% of its $43.5B portfolio in Q4 2023.
- John Overdeck opened 550 new positions and closed 366 in Q4 2023.
- John Overdeck's portfolio value rose 17% quarter-over-quarter to $43.5B.
Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.